Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Change in Receivables (2016 - 2025)

Arrowhead Pharmaceuticals' Change in Receivables history spans 16 years, with the latest figure at $212.0 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 8381.84% year-over-year to $212.0 million; the TTM value through Dec 2025 reached $266.5 million, up 10560.52%, while the annual FY2025 figure was $57.0 million, N/A changed from the prior year.
  • Change in Receivables reached $212.0 million in Q4 2025 per ARWR's latest filing, up from $47.1 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $212.0 million in Q4 2025 to a low of -$68.2 million in Q2 2023.
  • Average Change in Receivables over 5 years is $16.3 million, with a median of $1.2 million recorded in 2022.
  • Peak YoY movement for Change in Receivables: tumbled 9960.0% in 2021, then surged 8381.84% in 2025.
  • A 5-year view of Change in Receivables shows it stood at -$10.1 million in 2021, then skyrocketed by 477.61% to $38.2 million in 2022, then tumbled by 103.27% to -$1.2 million in 2023, then soared by 300.64% to $2.5 million in 2024, then soared by 8381.84% to $212.0 million in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Change in Receivables are $212.0 million (Q4 2025), $47.1 million (Q3 2025), and $7.5 million (Q2 2025).